ENST00000323374.8:c.95C>G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The ENST00000323374.8(SPHK1):​c.95C>G​(p.Ala32Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000213 in 1,408,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A32V) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

SPHK1
ENST00000323374.8 missense

Scores

1
15

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.67

Publications

4 publications found
Variant links:
Genes affected
SPHK1 (HGNC:11240): (sphingosine kinase 1) The protein encoded by this gene catalyzes the phosphorylation of sphingosine to form sphingosine-1-phosphate (S1P), a lipid mediator with both intra- and extracellular functions. Intracellularly, S1P regulates proliferation and survival, and extracellularly, it is a ligand for cell surface G protein-coupled receptors. This protein, and its product S1P, play a key role in TNF-alpha signaling and the NF-kappa-B activation pathway important in inflammatory, antiapoptotic, and immune processes. Phosphorylation of this protein alters its catalytic activity and promotes its translocation to the plasma membrane. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06635329).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000323374.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPHK1
NM_001142601.2
MANE Select
c.-164C>G
5_prime_UTR
Exon 2 of 6NP_001136073.1Q9NYA1-1
SPHK1
NM_182965.3
c.95C>Gp.Ala32Gly
missense
Exon 2 of 6NP_892010.2Q9NYA1-2
SPHK1
NM_021972.4
c.-164C>G
5_prime_UTR
Exon 2 of 6NP_068807.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPHK1
ENST00000323374.8
TSL:1
c.95C>Gp.Ala32Gly
missense
Exon 2 of 6ENSP00000313681.3Q9NYA1-2
SPHK1
ENST00000592299.6
TSL:1 MANE Select
c.-164C>G
5_prime_UTR
Exon 2 of 6ENSP00000465726.2Q9NYA1-1
SPHK1
ENST00000590959.5
TSL:1
c.-164C>G
5_prime_UTR
Exon 2 of 6ENSP00000468547.1Q9NYA1-3

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD2 exomes
AF:
0.00000593
AC:
1
AN:
168766
AF XY:
0.0000107
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000139
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000213
AC:
3
AN:
1408032
Hom.:
0
Cov.:
60
AF XY:
0.00000287
AC XY:
2
AN XY:
697360
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32394
American (AMR)
AF:
0.00
AC:
0
AN:
40118
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25396
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37582
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81404
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35464
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4104
European-Non Finnish (NFE)
AF:
0.00000274
AC:
3
AN:
1093032
Other (OTH)
AF:
0.00
AC:
0
AN:
58538
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.2
DANN
Benign
0.94
Eigen
Benign
-0.91
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.049
N
LIST_S2
Benign
0.46
T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.066
T
MetaSVM
Benign
-1.0
T
PhyloP100
-2.7
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.65
N
REVEL
Benign
0.013
Sift
Benign
0.053
T
Sift4G
Benign
0.17
T
Polyphen
0.28
B
Vest4
0.12
MutPred
0.12
Gain of catalytic residue at A32 (P = 0.0715)
MVP
0.085
MPC
0.38
ClinPred
0.051
T
GERP RS
-2.6
PromoterAI
-0.049
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201987985; hg19: chr17-74381562; API